Researcher
Sandrine Aspeslagh
- Keywords:Medicine
Affiliations
- Internal medicine (Department)
Member
From1 May 2023 → Today - Laboratory for Medical and Molecular Oncology (Research group)
Member
From22 Mar 2021 → Today - Medical Oncology (Department)
Member
From1 Feb 2019 → Today - Clinical sciences (Department)
Member
From1 Feb 2021 → Today - Clinical sciences (Department)
Member
From1 Feb 2021 → 20 Oct 2022 - Clinical sciences (Department)
Member
From15 Nov 2020 → 14 Nov 2022
Projects
1 - 1 of 1
- FORX - FOod interventions to Reduce immunotherapy toXicityFrom1 Nov 2023 → TodayFunding: FWO fellowships
Publications
61 - 70 of 71
- Rapid and objective CT scan prognostic scoring identifies metastatic patients with long-term clinical benefit on anti-PD-1/-L1 therapy(2016)
Authors: Laurent Dercle, Samy Ammari, Stéphane Champiat, Christophe Massard, Charles Ferté, Lokmane Taihi, Romain-David Seban, Sandrine Aspeslagh, Linda Mahjoubi, Nyam Kamsu-Kom, et al.
Pages: 33-42 - Acquired EGFR Mutation as the Potential Resistance Driver to Crizotinib in a MET-Mutated Tumor(2016)
Authors: Marc-Antoine Benderra, Sandrine Aspeslagh, Sophie Postel-Vinay, Ludovic Bigot, Thierry De Baere, Yohann Loriot, Ludovic Lacroix, Christophe Massard, Gilles Vassal, Fabrice André, et al.
Pages: e21-23 - Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies(2016)
Authors: Sophie Postel-Vinay, S Aspeslagh, Emilie Lanoy, Christophe Robert, Jean-Charles Soria, Aurélien Marabelle
Pages: 214-224 - Cancer immunotherapy(2016)
Authors: Linda Cairns, Sandrine Aspeslagh, Andrea Anichini, Jon Amund Kyte, Christian Blank, Paolo A Ascierto, Nicolle Rekers, Per Thor Straten, Ahmad Awada
- Rationale for anti-OX40 cancer immunotherapy(2016)
Authors: Sandrine Aspeslagh, Sophie Postel-Vinay, Sylvie Rusakiewicz, Jean-Charles Soria, Laurence Zitvogel, Aurélien Marabelle
Pages: 50-66 - Upcoming innovations in lung cancer immunotherapy(2015)
Authors: Sandrine Aspeslagh, Aurélien Marabelle, Jean-Charles Soria, Jean-Pierre Armand
- Synthesis of C-5″ and C-6″-modified α-GalCer analogues as iNKT-cell agonists(2015)
Authors: Joren Guillaume, Nora Pauwels, Sandrine Aspeslagh, Dirk M Zajonc, Dirk Elewaut, Serge Van Calenbergh
Pages: 3175-3182 - An in silico approach for modelling T-helper polarizing iNKT cell agonists(2014)
Authors: Anton De Spiegeleer, Evelien Wynendaele, Matthias Vandekerckhove, Sofie Stalmans, Maxime Boucart, Nele Van Den Noortgate, Koen Venken, Serge Van Calenbergh, Sandrine Aspeslagh, Dirk Elewaut
- Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection(2013)
Authors: Sandrine Aspeslagh, Marek Nemčovič, Nora Pauwels, Koen Venken, Jing Wang, Serge Van Calenbergh, Dirk M Zajonc, Dirk Elewaut
Pages: 2916-2925 - Activated iNKT cells promote memory CD8+ T cell differentiation during viral infection(2012)
Authors: Emma C Reilly, Elizabeth A Thompson, Sandrine Aspeslagh, Jack R Wands, Dirk Elewaut, Laurent Brossay